Secukinumab for treatment of nail psoriasis: results from the TRANSFIGURE trial

Affiliations

¹ St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, U.K.
² St John's Institute of Dermatology, Kings College London, London, U.K.

Comment

E Kloczko et al. Br J Dermatol. 2019 Nov.

. 2019 Nov;181(5):885-886.

doi: 10.1111/bjd.18439. Epub 2019 Sep 9.

¹ St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, U.K.
² St John's Institute of Dermatology, Kings College London, London, U.K.

No abstract available

Comment on

Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32-week results from the randomized placebo-controlled TRANSFIGURE trial.
Reich K, Sullivan J, Arenberger P, Mrowietz U, Jazayeri S, Augustin M, Parneix A, Regnault P, You R, Milutinovic M. Reich K, et al. Br J Dermatol. 2019 Nov;181(5):954-966. doi: 10.1111/bjd.17351. Epub 2019 Jan 16. Br J Dermatol. 2019. PMID: 30367462 Clinical Trial.

1. McClanahan DR, English JC 3rd. Therapeutics for adult nail psoriasis and nail lichen planus: a guide for clinicians. Am J Clin Dermatol 2018; 19:559-84.
1. Baran R. The burden of nail psoriasis: an introduction. Dermatology 2010; 221 (Suppl. 1):1-5.
1. Rigopoulos D, Baran R, Chiheb S et al. Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: a dermatologist and nail expert group consensus. J Am Acad Dermatol 2019; 81:228-40.
1. de Vries ACQ, Bogaards NA, Hooft L et al. Interventions for nail psoriasis (Cochrane Review). Cochrane Database Syst Rev 2013; 1:CD007633.
1. Gumusel M, Ozdemir M, Mevlitoglu I et al. Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: a one-blind, randomized study. J Eur Acad Dermatol Venereol 2011; 25:1080-4.